Brochure More information from

Transcription

1 Brochure More information from Global Depression Therapy & Treatment Market - Depression drugs and devices, Anxiety Disorders, SSRIs, Global Industry Analysis, Size, Share, Growth, Trends And Forecast Description: "Global Depression Therapy & Treatment Market Depression drugs and devices, Anxiety Disorders, SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Psychoanalysis, Cognitive Behavior, Psychodynamic, Electroconvulsive Pipeline Analysis, Physical Therapy Market, Global Industry Analysis, Size, Share, Growth, Trends And Forecast " Depression treatment market is segmented on the basis of antidepressants drugs, devices and therapies. Antidepressants are the largest market segment. Antidepressants are the most popular treatment methods. Every year more than five billion prescriptions are written globally. Antidepressants segment consists of big pharmaceuticals companies like Eli Lily, Pfizer, GlaxoSmithKline and Forest Laboratories. All these companies are branded drug manufacturers. Some of the popular drugs produced by these companies are Cymbalta (Eli Lily) and Effexor and Pristiq (Pfizer). The devices market is the fastest growing market segment. This Research Report covers: 1. Historical data 2. Revenue forecasts, growth rates and CAGR upto Industry Analysis 4. Competitive Analysis 5. Key geographic growth data 6. Deep profiles top competitive companies Contents: 1. Executive Summary 1.1. Depression therapy, device and drugs market 1.2. Methodology For Market Estimation 2. Market Overview -Depression Is A Major Concern Worldwide 2.1. Introduction 2.2. Depression is most common in years of age group 2.3. Types of Depressions Seasonal Affective Disorder (SAD) Uni-polar or Major Depression Dysthymia or Dysthymia Disorder Postpartum Depression Atypical Depression Psychotic Depression Bipolar Disorder 2.4. Value Chain Analysis For Drugs Manufacturers Distributors Retailers End-Users For Devices Manufacturers Distributors End-Users 2.5. Drivers Growing acceptance of Depression in the developing nations Increase in sales of antidepressants due to unhealthy life styles 2.6. Restraints High price of Psycho therapy is a major restraint Patents expiry is a major issue

2 Regulatory Compliance is important for the market to grow 2.7. Challenges Generic Vs Branded - leads to price reduction 2.8. Opportunities Significant Unmet Clinical needs has tremendous market potential Decline in drug market offset bygrowing demand for personal therapies & devices 2.9. Key Findings Negative Growth Rate in Antidepressants market Rising acceptance for depression treatment in Asia Pacific Market is shifting from branded to generic drugs Strategic Recommendations Market needs new anti depressant drugs 3. Market Segmentation 3.1. Antidepressants 3.2. Consumption of Antidepressants Generic Drugs are preferred OVER Branded Antidepressants due to lower cost 3.3. Selective serotonin reuptake inhibitors (SSRIs) Prozac (Fluoxetine) Paroxetine (Paxil) SERTRALINE (Zoloft) Escitalopram oxalate (Lexapro) Citalopram (Celexa) Serotonin and norepinephrine reuptake inhibitors (SNRIs) Duloxetine (Cymbalta) Effexor Norepinephrine and dopamine reuptake inhibitors (NDRIs) 3.4. Atypical antidepressants Trazodone Tricyclic antidepressants (TCA) Tofranil (Imipramine) Monoamine oxidase inhibitors (MAOIs) Tranylcypromine (Parnate) Phenelzine (Nardil) Other medications 3.5. Therapies Cognitive Behavior Therapy (CBT) Electroconvulsive Therapy (ECT) Rational emotive behavior therapy (REBT) Device enabled therapies Transcranial Magnetic Stimulation (TMS) therapy Deep Brain Stimulation Vagus Nerve Stimulator Virtual Reality (VR) Smart phone applications Other Therapies Ketamine therapy Special Conditions Antidepressants discontinuation syndrome (ADS) Treatment-resistant depression Rehabilitation centre for depression Rehabilitation programs through VR technology 4. Depression Prevalence by Gender 4.1. Depression in Men 4.2. Depression in Women Depression in Elderly is a common phenomenon 5. Resurgent Generic Drugs market due to patent expiry 6. Competitive Trends, Strategies & Market Share 6.1. Key Focus on Cost Control Impacting R&D Initiatives 6.2. Partnerships and acquisitions 6.3. Generic drug manufacturers focusing on patent expiration and semi regulated markets 6.4. Market Share Analysis 7. Geographical analysis 7.1. Devices market is growing in North America, Europe and Asia Pacific

3 7.2. North America is the highest drug market for depression US has the largest patient pool for depression drugs & devices US market is driven by strict regulations Mental illness is a major disease in Canada 7.3. Depression is a major concern in Europe almost 16.7 million people suffer from depression in the UK Regulations in the United Kingdom France has the highest rate of depression amongst developed nations Germany has prevalence rate of 4.5-5% for depression Spain has strict regulations for depression drugs 7.4. Asia Pacific has a strongly emerging generic drugs market Approx 60% of the population in China is undiagnosed for depression India has over 10 million people suffering from depression Financial burden of depression in Japan amounts to nearly $15 billion Depression is a common occurring health issue in the age group years in Australia 8. Corporate profiling 8.1. Pfizer Overview Strategic Analysis SCOT Analysis 8.2. GlaxoSmithKline Overview SCOT Analysis 8.3. Forest Laboratories Overview SCOT Analysis 8.4. Abbot Laboratories Overview SCOT Analysis 8.5. Eli Lilly and Company Overview SCOT Analysis 8.6. Merck Sharp &Dohme Overview SCOT Analysis 8.7. Sanofi Overview SCOT Analysis 8.8. Neuronetics Overview SCOT Analysis 8.9. Teva pharmaceuticals Industries Overview SCOT Analysis Mayo Clinic Overview Mayo Clinic product portfolio in depression therapy SCOT Analysis Sun Pharmaceuticals Overview SCOT Analysis Brainsway Overview SCOT Analysis Fisher Wallace Overview SCOT Analysis MagVentures Overview Lundbeck Overview Strategic moves SCOT Analysis

4 8.16. BoehringerIngelheim GmbH Overview SCOT Analysis Roche Holding AG Overview Strategic Moves SCOT Analysis List of Tables: Table 1 Global Depression Drugs and Devices Market (In $million) Table 2 Timeline of the branded drug expiration/launch in the U.S. Table 3 R& D spending by pharmaceutical giants in 2013 Table 4 Global antidepressants drug market, (in $million) Table 5 Price of Flouoxetine in different drug store in 2012 Table 6 Price of Paroxetine (Paxil), North America Table 7 Global Sertaline drug market, , (in $million) Table 8 Price and drug attribute of Lexapro Table 9 Price and Package details of Cymbalta Table 10 Table: U.S. Price of Effexor of different strength Table 11 Price of Bupropion (Wellbutrin) Table 12 Price of Trazodone of different strength Table 13 Price of Tofranil of different strength Table 14 Price of Tranylcypromine (Parnate) Table 15 Global virtual reality in healthcare market, (in $million) Table 16 Difference between male and female depression behavior Table 17 Global depression drugs and device market, , ($million) Table 18 North America depression drugs and device market, , (in $million) Table 19 France has the highest prevalence rate in EU in (2014) Table 20 European depression therapy and device market, , ($million) Table 21 Asia Pacific depression drugs and device market, , (in $million) Table 22 Pfizer product portfolio in depression therapy Table 23 GlaxoSmithKline product portfolio in depression therapy: Table 24 Forest Laboratories product portfolio in depression therapy Table 25 Abbot Laboratories product portfolio in depression therapy Table 26 Eli Lilly and Company product portfolio in depression therapy Table 27 Sanofi product portfolio in depression therapy Table 28 Neuronetics products portfolio in depression therapy Table 29 Teva pharmaceuticals Industries product portfolio in depression therapy Table 30 MagVentures product portfolio in depression therapy Table 31 Lundbeck product portfolio in depression therapy Table 32 Roche AG product portfolio in depression therapy List of Figures: Figure 1 DEPRESSION PREVALANCE-FACT SHEET Figure 2 Worldwide Prevalence of depression by age and gender in 2013 Figure 3 High rate of depression in American Indian and Alaska Native -12 month prevalence of major depressive episode among U.S. adults (2012) Figure 4 Lifetime prevalence RATE OF DEPRESSION IN US ADULTS, 2012 Figure 5 Dysthymia PATIENTS BY TREATMENT Figure 6 Value Chain of Antidepressant drugs Figure 7 Value Chain Analysis for Device Market Figure 8 CAUSES OF DEPRESSION-(FACTORS BY PERCENTAGE, 2013) Figure 9 Branded Antidepressant drug sales in $million ( ) Figure 10 Global Antidepressants drug market in $million ( ) Figure 11 Savings through generic drug usage in the United States in $billion ( ) Figure 12 Side effects of antidepressants Figure 13 Global Flouoxetine market, , (in $million) Figure 14 Global Escilatopram drug market, (in $million) Figure 15 Price of Citalopram (Celexa) Figure 16 Global Duloexitine market, , (in $million) Figure 17 Global Venlafexine drug market, , ($million)

5 Figure 18 Global Transcranial Magnetic Stimulation Market, (in $million) Figure 19 Global Deep Brain Stimulation Market, , (in $million) Figure 20 Global Vagus Nerve Stimulation Market, (in $million) Figure 21 COMPARISON OF MALE AND FEMALE DEPRESSION Figure 22 Market Share of major antidepressants in 2021 (%) Figure 23 Market Share of antidepressants drug manufacturers (percentage of sales), 2014 Figure 24 GEOGRAPHICAL DISTRIBUTION OF prevalence rate of depression, 2013 Figure 25 Devices Market (percentage sales) to be the largest in 2021 Figure 26 The U.S. depression therapy market, ($million) Figure 27 Canada depression therapy market, , ($million) Figure 28 European depression treatment device and therapy market, ($million) Figure 29 Devices market will double (percentage sales) in 2021 from 2013 Figure 30 Total cost of mental illness in England (in $) Figure 31 United Kingdom depression therapy market, ($million) Figure 32 France depression therapy market, ($million) Figure 33 Germany depression therapy market, ($million) Figure 34 Spain depression therapy market, ($million) Figure 35 China depression therapy market, , ($million) Figure 36 India depression therapy market, , ($million) Figure 37 Japan depression therapy market, , ($million) Figure 38 Australia depression Therapy market, , ($million) Figure 39 Sun Pharmaceuticals products portfolio in depression therapy Figure 40 Brainsway product portfolio in depression therapy Figure 41 Fisher Wallace product portfolio in depression therapy Ordering: Order Online - Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

6 Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to (from USA) or (from Rest of World). If you have any questions please visit Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Web Address: Office Code: Global Depression Therapy & Treatment Market - Depression drugs and devices, Anxiety Disorders, SSRIs, Global Industry Analysis, Size, Share, Growth, Trends And Forecast SC Product Formats Please select the product formats and quantity you require: Electronic (PDF) - Single User: Electronic (PDF) - Enterprisewide: Quantity USD 4000 USD 6000 Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: Last Name: Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free accounts when ordering (e.g. Yahoo, Hotmail, AOL)

7 Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number Sort code Swift code IBAN number Bank Address ULSBIE2D IE78ULSB Ulster Bank, Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at Please fax this form to: (646) or (646) From USA or From Rest of World